InvestorsHub Logo

Tasso9

05/09/18 7:41 PM

#11918 RE: Theboy56 #11917

Why would they? Strange question. On the contrary they will soon be starting a study 2A on montelukast for mild case of Alzheimer's as well continuing on the rest of their pipeline look it up